We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EVEX:NYSEEve Holding, Inc. Analysis

Data as of 2026-09-19 - not real-time

$2.04

Latest Price

9/10Risk

Risk Level: High

Executive Summary

At $2.04, Eve Holding, Inc. shows a bearish moving-average alignment, with shorter averages beneath longer ones. It has lost 22.1% over the past 30 days. With RSI at 34.6 the momentum picture is approaching oversold, alongside a bearish MACD signal. Recent trading has carved out support near $1.99 and resistance around $2.73.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 208.2% above the current quote.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 46.6%, a beta of 2.77 and a maximum drawdown of 60.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Across every horizon the signals point the same way: sell, at a conviction of 5 out of 10.

Top Market Events

Eve Holding Inc EVEX reports strong liquidity and strategic synergies with Embraer, while navigating certification...Eve Holding, Inc. "Eve" NYSE: EVEX and EVEXW / B3: EVEB31 reports its second quarter 2026 earnings results./PRNewswire/ -- Eve Holding, Inc. "Eve" NYSE: EVEX and EVEXW / B3: EVEB31 reports its second quarter 2026 earnings...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 3.10
  • MACD momentum is negative

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 3.10
  • Analyst targets imply +208.2% versus the current price

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Analyst targets imply +208.2% versus the current price
  • Negative return on equity of -1179.2%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

P/E Ratio-3.6
ROE-1179.21%
ROA-38.69%
Debt/Equity1352.89
P/B Ratio30.9
Op. Cash Flow$-195239008
Free Cash Flow$-152526880
Industry P/E27.6

Technical Analysis

TrendBearish
RSI34.6
Support$1.99
Resistance$2.73
MA 20$2.24
MA 50$2.40
MA 200$3.10
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Target Price$6.29
Upside/Downside208.21%
GradeFair
TypeGrowth

Risk Assessment

Beta2.77
Volatility46.65%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.